Alkyl fluorides
Sigma Aldrich Fine Chemicals Biosciences Heptafluorobutyric acid 99
HEPTAFLUOROBUTYRIC9 Heptafluorobutyric acid 99
Medchemexpress LLC X-376 | 1365267-27-1 | 98.1% | 547.41 g·mol⁻¹ | C25H25Cl2FN6O3 | 10 MG
X-376 is a small-molecule tyrosine kinase inhibitor that potently targets anaplastic lymphoma kinase (ALK) and shows inhibitory activity against MET. It is supplied as a powder for preclinical research use and is suitable for cellular and in vivo studies of ALK-driven tumors.
- Potent ALK inhibition (IC50 0.61 nM).
- MET inhibitory activity (IC50 0.69 nM).
- Suitable for preclinical cellular and in vivo research.
- Supplied as a powder with recommended cold storage for stability.
- Molecular weight 547.41 g·mol⁻¹; formula C25H25Cl2FN6O3.
Medchemexpress LLC Perfluorohexanoic acid | 307-24-4 | 99.9% | 314.05 | 5 G
Perfluorohexanoic acid (Undecafluorocaproic acid) is a biological molecule. It is for research use only and not sold to patients. It is used as a laboratory chemical and in the manufacture of substances.
- Target: Biochemical assay reagents
- Stable under recommended storage conditions
- Recommended storage temperature: Store at room temperature for 3 years, in solvent at -80°C for 2 years or -20°C for 1 year
- Product is for research use only and for experienced personnel
SPEX CERTIPREP LLC 3P 2H,2H,3H,3H-Perfluorohexanoic acid; 50 µg/mL in MeOH with 4 mole eq. NaOH; 1 mL
2H,2H,3H,3H-Perfluorohexanoic acid; 50 µg/mL in MeOH with 4 mole eq. NaOH; 1 mL
SPEX CERTIPREP LLC 3P 2H,2H,3H,3H-Perfluorodecanoic acid; 50 µg/mL in MeOH with 4 mole eq. NaOH; 1 mL
2H,2H,3H,3H-Perfluorodecanoic acid; 50 µg/mL in MeOH with 4 mole eq. NaOH; 1 mL
SPEX CERTIPREP LLC 3P 2H,2H,3H,3H-Perfluorooctanoic acid; 50 µg/mL in MeOH with 4 mole eq. NaOH; 1 mL
2H,2H,3H,3H-Perfluorooctanoic acid; 50 µg/mL in MeOH with 4 mole eq. NaOH; 1 mL
SPEX CERTIPREP LLC 3P Perfluorobutyric acid; 50 µg/mL in MeOH with 4 mole eq. NaOH; 1 mL
Perfluorobutyric acid; 50 µg/mL in MeOH with 4 mole eq. NaOH; 1 mL
BIOHIPPO Research Grade Anti-Human CD266/TNFRSF12A Biosimilar Antibody (BAY-356), 100 µg
BAY-356 is a research-grade biosimilar antibody targeting CD266/TNFRSF12A. It reacts with Human. Suitable for ELISA, FACS, Functional assay, Research in vivo. This research-grade biosimilar supports comparability, functional, PK/PD and immunogenicity studies. Supplied as 100 ug.
Medchemexpress LLC LMP2A (426-434) | 152274-91-4 | 96.1% | 906.16 | 25 MG
LMP2A (426-434) is an HLA-A2-restricted cytotoxic T lymphocyte (CTL) epitope of Epstein-Barr virus (EBV) latent membrane protein 2A (LMP2A). It can trigger an immune response in individuals expressing various HLA-A*02 subtypes and induces a strong IFN-γ secretion response, leading to a high proportion of CD8+ IFN-γ+ T cells. It induces specific CTLs that effectively kill target cells expressing LMP2A.
- Suitable for studying EBV-related malignant tumors, such as Hodgkin's disease and nasopharyngeal carcinoma.
- Induces IFN-γ secreting cells at a frequency of 80.6 SFC/5x10⁴ CD8+ T cells (at 20 μg/mL for 24 h).
- Significantly increases the proportion of CD8+IFN-γ+ cells after two weeks of stimulation (at 20 μg/mL).
- Specific CTLs effectively kill peptide-pulsed T2 cells and 293T-LMP2A cells (at 20 μg/mL for 4 h).
Medchemexpress LLC Lmp2a (426-434) | 152274-91-4 | 96.1% | 906.16 | 5 MG
LMP2A (426-434) is a HLA-A2-restricted cytotoxic T lymphocyte (CTL) epitope of Epstein-Barr virus (EBV) latent membrane protein 2A (LMP2A). It can trigger an immune response in individuals expressing different HLA-A*02 subtypes (A*02:01, A*02:03, A*02:06, and A*02:07). This peptide induces a strong IFN-γ secretion response, stimulating the production of a high proportion of CD8+ IFN-γ+ T cells. It also induces specific CTLs to effectively kill target cells expressing LMP2A. It is used in the study of EBV-related malignant tumors such as Hodgkin's disease and nasopharyngeal carcinoma.
- Induces IFN-γ secreting cells at a frequency of 80.6 SFC/5x10⁴ CD8+ T cells (at 20 μg/mL for 24 h).
- Significantly increases the proportion of CD8+IFN-γ+ cells (at 20 μg/mL for 2 weeks).
- Specific CTLs effectively kill peptide-pulsed T2 cells and 293T-LMP2A cells (at 20 μg/mL for 4 h).
Medchemexpress LLC GluN1(356-385) | 99.95% | 3415.90 | 1 MG
GluN1 (356-385) is an antigenic peptide developed for the study of N-methyl-D-aspartate receptor (NMDAR) encephalitis. It functions by reducing the density of surface NMDAR clusters in hippocampal neurons, offering a tool to understand the pathogenesis of anti-NMDAR encephalitis.
- Antigenic peptide against NMDAR encephalitis
- Reduces density of surface NMDAR clusters in hippocampal neurons
- Useful for studying anti-NMDAR encephalitis pathogenesis
FUJIFILM Biosciences UNDECAFLUOROHEANOIC ACID, 1G
*Orders for this supplier are non-cancellable/non-returnable once they are processed.* Undecafluoroheanoic Acid, 1g. 307-24-4 MFCD00198040